Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kenvue Inc. Common Stock (KVUE) vs Vanguard Growth Index Fund ETF (VUG) Price & Performance

Kenvue Inc. Common StockTrade
Vanguard Growth Index Fund ETFTrade

Price performance (Past 24H)

Key statistics

Kenvue Inc. Common Stock vs Vanguard Growth Index Fund ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.68 (market cap $34.06B), while Vanguard Growth Index Fund ETF trades at $92.09 (market cap $384.60B). The key difference: Vanguard Growth Index Fund ETF is far larger — about 11.3× Kenvue Inc. Common Stock's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Vanguard Growth Index Fund ETF pays none. Which is the better fit depends on your goals.

KVUEVUG
Market Cap
$34.06B$384.60B
Volume
23,267,2285,662,307
Sector
Consumer StaplesSector/Thematic
52-Week High
$19.83$92.64
52-Week Low
$14.11$70.00
Enterprise Value
$41.56B—
Dividend Yield
4.74%—
Typical Hold Time
—47 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Kenvue Inc. Common Stock

No Aura AI signal available yet.

Vanguard Growth Index Fund ETF

VUG trades at $91.97, down 0.49% with a bullish technical signal supported by moving averages. The ETF holds dominant positions in mega-cap tech stocks including Nvidia, Apple, and Microsoft, which comprise over 36% of holdings. Recent financial media coverage highlights VUG's historical annual returns averaging 11-12% since its 2004 inception, positioning it as a long-term growth vehicle for investors with multi-decade horizons.

The outlook remains positive for long-term investors seeking growth exposure, though concentration in technology stocks presents sector-specific risks. Current technical levels show support at $89-91 with resistance at $92-94. The neutral oscillator readings suggest potential for consolidation near current levels before further directional movement.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KVUE

No sentiment data available yet.

VUG
96% Buy4% Sell
Avg holding period · 47 Days

Top news

Latest headlines on both assets

About Kenvue Inc. Common Stock

Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.

Read more on KVUE →

About Vanguard Growth Index Fund ETF

VUG is an index-based ETF that tracks the CRSP US Large Cap Growth Index, providing concentrated exposure to the largest and fastest-growing companies in the United States. It focuses on stocks with high growth potential across tech, communication, and consumer sectors, serving as a low-cost, high-conviction core holding for long-term capital appreciation.

Read more on VUG →